Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-04

AUTHORS

Paola Queirolo, Marco Ponte, Marco Gipponi, Ferdinando Cafiero, Alberto Peressini, Claudia Semino, Gabriella Pietra, Rita Lionetto, Stefania Vecchio, Iole Ribizzi, Giovanni Melioli, Mario R. Sertoli, Melanoma Istituto Scientifico Tumori Group

ABSTRACT

BACKGROUND: On the basis of our previous experience, we designed this study to determine the activity and toxicity of outpatient treatment with autologous tumor-infiltrating lymphocytes (TIL) together with intermediate-dose recombinant interleukin-2 (rIL-2) and low-dose recombinant interferon alfa-2a (rIFN-alpha2a), for patients with metastatic melanoma. METHODS: Between April 1992 and October 1994, we processed 38 melanoma samples derived from 36 patients with metastases. Proliferative cultures of expanded lymphocytes (TIL) were infused only once into patients with metastatic melanoma. rIL-2 was administered subcutaneously for 1 month, starting on the day of TIL infusion, at an escalating dose of 6-18 x 10(6) IU/m2/day for the first week and at the maximum-tolerated dose for the subsequent 3 weeks and then, after a 15-day interval, for 1 week/month for 3 months. rIFN-alpha2a was administered subcutaneously at 3 X 10(6) IU three times each week until progression. RESULTS: Of 38 melanoma samples, 19 (50%) resulted in proliferative cultures and were infused. The median number of expanded lymphocytes was 18 x 10(9) (range, 1-43 x 10(9)), and the median period of culture was 52 days (range, 45-60). rIL-2 was administered at doses ranging between 6 and 18 x 10(6) IU/m2/day. Toxicity was mild or moderate, and no life-threatening side effects were encountered. Two of 19 treated patients experienced complete responses of their metastatic sites (soft tissue), 10 had stable disease, and 7 showed progressive disease. The response rate was 11% (95% confidence interval, 2-35%). CONCLUSIONS: Outpatient treatment with TIL plus rIL-2 and rIFN-alpha2a is feasible, although, within the context of the small sample size, the activity of the combination was no different from the reported activity of any of the components used alone. More... »

PAGES

272-278

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10434-999-0272-4

DOI

http://dx.doi.org/10.1007/s10434-999-0272-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010384016

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10340886


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy, Adoptive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon alpha-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphatic Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes, Tumor-Infiltrating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Queirolo", 
        "givenName": "Paola", 
        "id": "sg:person.01102114523.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102114523.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Surgical Oncology, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ponte", 
        "givenName": "Marco", 
        "id": "sg:person.01110652473.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110652473.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "The Melanoma IST Group participants were Marina Bergaglio, Franco De Cian, Franco Di Somma, Francesco Filippi, Maria Luisa Rainero, and Franco Belmondo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gipponi", 
        "givenName": "Marco", 
        "id": "sg:person.01272275041.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272275041.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "The Melanoma IST Group participants were Marina Bergaglio, Franco De Cian, Franco Di Somma, Francesco Filippi, Maria Luisa Rainero, and Franco Belmondo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cafiero", 
        "givenName": "Ferdinando", 
        "id": "sg:person.01130076740.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130076740.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Surgical Oncology, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peressini", 
        "givenName": "Alberto", 
        "id": "sg:person.01156230741.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156230741.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Surgical Oncology, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Semino", 
        "givenName": "Claudia", 
        "id": "sg:person.01264406000.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264406000.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Surgical Oncology, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pietra", 
        "givenName": "Gabriella", 
        "id": "sg:person.01140414625.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140414625.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Surgical Oncology, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lionetto", 
        "givenName": "Rita", 
        "id": "sg:person.01033554132.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033554132.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vecchio", 
        "givenName": "Stefania", 
        "id": "sg:person.01135120604.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135120604.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ribizzi", 
        "givenName": "Iole", 
        "id": "sg:person.01141433133.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141433133.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Surgical Oncology, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Melioli", 
        "givenName": "Giovanni", 
        "id": "sg:person.01274627641.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274627641.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sertoli", 
        "givenName": "Mario R.", 
        "id": "sg:person.01100026616.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100026616.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Advanced Biotechnology Center, National Cancer Institute of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Melanoma Istituto Scientifico Tumori Group", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002732031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198910000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003070692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198910000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003070692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.161.5.1169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008495351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-199404000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008747279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-199404000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008747279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910280307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011013967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198704093161502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016780262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(89)91609-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021609526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19960715)78:2<244::aid-cncr9>3.0.co;2-l", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022318742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.155.6.1823", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035987844"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/291335a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036146781", 
          "https://doi.org/10.1038/291335a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.66", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048333305", 
          "https://doi.org/10.1038/bjc.1995.66"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.66", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048333305", 
          "https://doi.org/10.1038/bjc.1995.66"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049278910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(19960208)65:4<413::aid-ijc3>3.0.co;2-#", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051801158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(89)90015-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053744925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(89)90015-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053744925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/86.15.1159", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059818758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.181845", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062508258"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.3489291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062616710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.6332379", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062636819"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/or.4.1.27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071535320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.annonc.a058261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076800116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1992.10.2.275", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077377500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.4.641", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078193758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.10.1657", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078482791"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.7.1138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1989.7.12.1863", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079223212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1989.7.11.1726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079394454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/75.4.595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1080008874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080018650", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1984.2.4.336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1081679323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1995.13.8.1939", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082444239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1994.12.7.1475", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082613204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1994.12.8.1572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082622190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.10.1969", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082794839"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-04", 
    "datePublishedReg": "1999-04-01", 
    "description": "BACKGROUND: On the basis of our previous experience, we designed this study to determine the activity and toxicity of outpatient treatment with autologous tumor-infiltrating lymphocytes (TIL) together with intermediate-dose recombinant interleukin-2 (rIL-2) and low-dose recombinant interferon alfa-2a (rIFN-alpha2a), for patients with metastatic melanoma.\nMETHODS: Between April 1992 and October 1994, we processed 38 melanoma samples derived from 36 patients with metastases. Proliferative cultures of expanded lymphocytes (TIL) were infused only once into patients with metastatic melanoma. rIL-2 was administered subcutaneously for 1 month, starting on the day of TIL infusion, at an escalating dose of 6-18 x 10(6) IU/m2/day for the first week and at the maximum-tolerated dose for the subsequent 3 weeks and then, after a 15-day interval, for 1 week/month for 3 months. rIFN-alpha2a was administered subcutaneously at 3 X 10(6) IU three times each week until progression.\nRESULTS: Of 38 melanoma samples, 19 (50%) resulted in proliferative cultures and were infused. The median number of expanded lymphocytes was 18 x 10(9) (range, 1-43 x 10(9)), and the median period of culture was 52 days (range, 45-60). rIL-2 was administered at doses ranging between 6 and 18 x 10(6) IU/m2/day. Toxicity was mild or moderate, and no life-threatening side effects were encountered. Two of 19 treated patients experienced complete responses of their metastatic sites (soft tissue), 10 had stable disease, and 7 showed progressive disease. The response rate was 11% (95% confidence interval, 2-35%).\nCONCLUSIONS: Outpatient treatment with TIL plus rIL-2 and rIFN-alpha2a is feasible, although, within the context of the small sample size, the activity of the combination was no different from the reported activity of any of the components used alone.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10434-999-0272-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "name": "Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A Phase I/II Pilot Trial", 
    "pagination": "272-278", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "31787a108dd0e2fc9886208de9985a8f741fd584e31b754ae7d78dd2e32c2827"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10340886"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10434-999-0272-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010384016"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10434-999-0272-4", 
      "https://app.dimensions.ai/details/publication/pub.1010384016"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13071_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s10434-999-0272-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10434-999-0272-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10434-999-0272-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10434-999-0272-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10434-999-0272-4'


 

This table displays all metadata directly associated to this object as RDF triples.

332 TRIPLES      21 PREDICATES      79 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10434-999-0272-4 schema:about N2803b952c6ec4866a49375c751220e6f
2 N4d94f0682437404fbc564fcc02390b3f
3 N5eeef8ca8219489abc15553d0ad5583a
4 N70072df1efb44f78891d3122642416e2
5 N77e4dc59d3c94b96b8629d4beb550cb4
6 N80489b2d19ae4141ab7cb6e11b5183f4
7 N837a94330c4c402c87132abefd97dce9
8 N977e563aa9e1497380549ce35e25f4a8
9 N987f2f7c384648e6b526358d2f9773a5
10 Ndcb00a92a9094a0ca5fbe3ab94a04442
11 Nddffa60d973546e382481d7c9b17f451
12 Nf2709be2d53c4a08b7e65ab955ae752c
13 Nf4d263b075304036b2411c7e48977d7b
14 Nf56593df67bd4d878c0669342649cdca
15 Nf68f95776c2c4e9da359ec75bc6ced21
16 Nfb540b5b993b453a9963fc28e3768144
17 Nfe15d6983ada44de99dea6b79419b45c
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author N340c8042fc4247fda9c4e9ac4fca84b7
21 schema:citation sg:pub.10.1038/291335a0
22 sg:pub.10.1038/bjc.1995.66
23 https://app.dimensions.ai/details/publication/pub.1080018650
24 https://doi.org/10.1002/(sici)1097-0142(19960715)78:2<244::aid-cncr9>3.0.co;2-l
25 https://doi.org/10.1002/(sici)1097-0215(19960208)65:4<413::aid-ijc3>3.0.co;2-#
26 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6
27 https://doi.org/10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k
28 https://doi.org/10.1002/ijc.2910280307
29 https://doi.org/10.1016/0197-2456(89)90015-9
30 https://doi.org/10.1016/s0140-6736(89)91609-7
31 https://doi.org/10.1056/nejm198704093161502
32 https://doi.org/10.1084/jem.155.6.1823
33 https://doi.org/10.1084/jem.161.5.1169
34 https://doi.org/10.1093/jnci/75.4.595
35 https://doi.org/10.1093/jnci/86.15.1159
36 https://doi.org/10.1093/oxfordjournals.annonc.a058261
37 https://doi.org/10.1097/00000658-198910000-00008
38 https://doi.org/10.1097/00008390-199404000-00007
39 https://doi.org/10.1126/science.181845
40 https://doi.org/10.1126/science.3489291
41 https://doi.org/10.1126/science.6332379
42 https://doi.org/10.1200/jco.1984.2.4.336
43 https://doi.org/10.1200/jco.1989.7.11.1726
44 https://doi.org/10.1200/jco.1989.7.12.1863
45 https://doi.org/10.1200/jco.1990.8.10.1657
46 https://doi.org/10.1200/jco.1990.8.7.1138
47 https://doi.org/10.1200/jco.1991.9.4.641
48 https://doi.org/10.1200/jco.1992.10.2.275
49 https://doi.org/10.1200/jco.1993.11.10.1969
50 https://doi.org/10.1200/jco.1994.12.7.1475
51 https://doi.org/10.1200/jco.1994.12.8.1572
52 https://doi.org/10.1200/jco.1995.13.8.1939
53 https://doi.org/10.3892/or.4.1.27
54 schema:datePublished 1999-04
55 schema:datePublishedReg 1999-04-01
56 schema:description BACKGROUND: On the basis of our previous experience, we designed this study to determine the activity and toxicity of outpatient treatment with autologous tumor-infiltrating lymphocytes (TIL) together with intermediate-dose recombinant interleukin-2 (rIL-2) and low-dose recombinant interferon alfa-2a (rIFN-alpha2a), for patients with metastatic melanoma. METHODS: Between April 1992 and October 1994, we processed 38 melanoma samples derived from 36 patients with metastases. Proliferative cultures of expanded lymphocytes (TIL) were infused only once into patients with metastatic melanoma. rIL-2 was administered subcutaneously for 1 month, starting on the day of TIL infusion, at an escalating dose of 6-18 x 10(6) IU/m2/day for the first week and at the maximum-tolerated dose for the subsequent 3 weeks and then, after a 15-day interval, for 1 week/month for 3 months. rIFN-alpha2a was administered subcutaneously at 3 X 10(6) IU three times each week until progression. RESULTS: Of 38 melanoma samples, 19 (50%) resulted in proliferative cultures and were infused. The median number of expanded lymphocytes was 18 x 10(9) (range, 1-43 x 10(9)), and the median period of culture was 52 days (range, 45-60). rIL-2 was administered at doses ranging between 6 and 18 x 10(6) IU/m2/day. Toxicity was mild or moderate, and no life-threatening side effects were encountered. Two of 19 treated patients experienced complete responses of their metastatic sites (soft tissue), 10 had stable disease, and 7 showed progressive disease. The response rate was 11% (95% confidence interval, 2-35%). CONCLUSIONS: Outpatient treatment with TIL plus rIL-2 and rIFN-alpha2a is feasible, although, within the context of the small sample size, the activity of the combination was no different from the reported activity of any of the components used alone.
57 schema:genre research_article
58 schema:inLanguage en
59 schema:isAccessibleForFree false
60 schema:isPartOf N5f66216ce9e040548dc762a833819dc6
61 Nae80d3c00bf0465c93c40eb786523016
62 sg:journal.1105545
63 schema:name Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A Phase I/II Pilot Trial
64 schema:pagination 272-278
65 schema:productId N7554e565ee6b4aa28a4f9830f26128a3
66 N889f166094c146d3baf484bdd31148b0
67 N9e571cb8a1704f66b19efde67ba34fd8
68 Nb081daf8483f40699d0305aab39ee0a7
69 Nb649efb1b71b4eba93b888e275ab9392
70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010384016
71 https://doi.org/10.1007/s10434-999-0272-4
72 schema:sdDatePublished 2019-04-11T14:26
73 schema:sdLicense https://scigraph.springernature.com/explorer/license/
74 schema:sdPublisher Nbd8ada0bf3d64edf95de75d2d8dce7b7
75 schema:url http://link.springer.com/10.1007/s10434-999-0272-4
76 sgo:license sg:explorer/license/
77 sgo:sdDataset articles
78 rdf:type schema:ScholarlyArticle
79 N074e8e80f97f4a949826a70e42396149 rdf:first sg:person.01156230741.17
80 rdf:rest Ne164ea25c54c47eaabfa9651ea5b7046
81 N0814fd383d0147d780673f1ffcb7b367 schema:name Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy
82 rdf:type schema:Organization
83 N0b93d7e4a03d46f782167bdb2b397f56 rdf:first sg:person.01141433133.33
84 rdf:rest N8e6425cd91424c448cab994120246082
85 N1674c5330d664607961a4a484727a949 rdf:first sg:person.01140414625.71
86 rdf:rest N18575e4391da4c3b97f4ac9cb03c6dac
87 N18575e4391da4c3b97f4ac9cb03c6dac rdf:first sg:person.01033554132.23
88 rdf:rest Nc93f0427b60c497a8592f58af1ebb74f
89 N2803b952c6ec4866a49375c751220e6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Male
91 rdf:type schema:DefinedTerm
92 N320966543a814fe4af91acb19d1ff995 rdf:first sg:person.01110652473.89
93 rdf:rest Nbfa35bc32e6b41e087706507b1f751e4
94 N340c8042fc4247fda9c4e9ac4fca84b7 rdf:first sg:person.01102114523.12
95 rdf:rest N320966543a814fe4af91acb19d1ff995
96 N3dfeda19587d494a9414905a81037c25 rdf:first Nab06d96a5d614175a6a18e0774359487
97 rdf:rest rdf:nil
98 N3f13e6a7bb424c0a8bf9121269693962 schema:name The Melanoma IST Group participants were Marina Bergaglio, Franco De Cian, Franco Di Somma, Francesco Filippi, Maria Luisa Rainero, and Franco Belmondo
99 rdf:type schema:Organization
100 N4d94f0682437404fbc564fcc02390b3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Lymphocytes, Tumor-Infiltrating
102 rdf:type schema:DefinedTerm
103 N5eeef8ca8219489abc15553d0ad5583a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Adult
105 rdf:type schema:DefinedTerm
106 N5f66216ce9e040548dc762a833819dc6 schema:volumeNumber 6
107 rdf:type schema:PublicationVolume
108 N6ac977dfe83f4b48b6923d2b1717b510 schema:name Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy
109 rdf:type schema:Organization
110 N70072df1efb44f78891d3122642416e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Drug Therapy, Combination
112 rdf:type schema:DefinedTerm
113 N7554e565ee6b4aa28a4f9830f26128a3 schema:name doi
114 schema:value 10.1007/s10434-999-0272-4
115 rdf:type schema:PropertyValue
116 N77e4dc59d3c94b96b8629d4beb550cb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Lymphatic Metastasis
118 rdf:type schema:DefinedTerm
119 N7df9c950eeee4729980e47a1bc4fb8e3 rdf:first sg:person.01100026616.95
120 rdf:rest N3dfeda19587d494a9414905a81037c25
121 N80489b2d19ae4141ab7cb6e11b5183f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Interferon-alpha
123 rdf:type schema:DefinedTerm
124 N837a94330c4c402c87132abefd97dce9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Skin Neoplasms
126 rdf:type schema:DefinedTerm
127 N889f166094c146d3baf484bdd31148b0 schema:name readcube_id
128 schema:value 31787a108dd0e2fc9886208de9985a8f741fd584e31b754ae7d78dd2e32c2827
129 rdf:type schema:PropertyValue
130 N88c94b78f0fb4ebdac4c1678a7e244e8 schema:name Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy
131 rdf:type schema:Organization
132 N8e6425cd91424c448cab994120246082 rdf:first sg:person.01274627641.56
133 rdf:rest N7df9c950eeee4729980e47a1bc4fb8e3
134 N977e563aa9e1497380549ce35e25f4a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Female
136 rdf:type schema:DefinedTerm
137 N987f2f7c384648e6b526358d2f9773a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Pilot Projects
139 rdf:type schema:DefinedTerm
140 N9d08dfd14f4549b0955a7abe9dea43a0 schema:name The Melanoma IST Group participants were Marina Bergaglio, Franco De Cian, Franco Di Somma, Francesco Filippi, Maria Luisa Rainero, and Franco Belmondo
141 rdf:type schema:Organization
142 N9e571cb8a1704f66b19efde67ba34fd8 schema:name pubmed_id
143 schema:value 10340886
144 rdf:type schema:PropertyValue
145 Nab06d96a5d614175a6a18e0774359487 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
146 schema:familyName Melanoma Istituto Scientifico Tumori Group
147 rdf:type schema:Person
148 Nac1a370dafe443b1b0b0dc988ccbeda4 schema:name Departments of Medical Oncology, University of Genoa, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132, Genoa, Italy
149 rdf:type schema:Organization
150 Nae80d3c00bf0465c93c40eb786523016 schema:issueNumber 3
151 rdf:type schema:PublicationIssue
152 Nb081daf8483f40699d0305aab39ee0a7 schema:name nlm_unique_id
153 schema:value 9420840
154 rdf:type schema:PropertyValue
155 Nb649efb1b71b4eba93b888e275ab9392 schema:name dimensions_id
156 schema:value pub.1010384016
157 rdf:type schema:PropertyValue
158 Nbd8ada0bf3d64edf95de75d2d8dce7b7 schema:name Springer Nature - SN SciGraph project
159 rdf:type schema:Organization
160 Nbfa35bc32e6b41e087706507b1f751e4 rdf:first sg:person.01272275041.40
161 rdf:rest Ne6c655ff4e9945fea2c9fd36b8eb74e0
162 Nc93f0427b60c497a8592f58af1ebb74f rdf:first sg:person.01135120604.05
163 rdf:rest N0b93d7e4a03d46f782167bdb2b397f56
164 Ndcb00a92a9094a0ca5fbe3ab94a04442 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Interleukin-2
166 rdf:type schema:DefinedTerm
167 Nddffa60d973546e382481d7c9b17f451 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Middle Aged
169 rdf:type schema:DefinedTerm
170 Ne164ea25c54c47eaabfa9651ea5b7046 rdf:first sg:person.01264406000.09
171 rdf:rest N1674c5330d664607961a4a484727a949
172 Ne6c655ff4e9945fea2c9fd36b8eb74e0 rdf:first sg:person.01130076740.81
173 rdf:rest N074e8e80f97f4a949826a70e42396149
174 Nf2709be2d53c4a08b7e65ab955ae752c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Humans
176 rdf:type schema:DefinedTerm
177 Nf4d263b075304036b2411c7e48977d7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Melanoma
179 rdf:type schema:DefinedTerm
180 Nf56593df67bd4d878c0669342649cdca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Interferon alpha-2
182 rdf:type schema:DefinedTerm
183 Nf68f95776c2c4e9da359ec75bc6ced21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Aged
185 rdf:type schema:DefinedTerm
186 Nfb540b5b993b453a9963fc28e3768144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Recombinant Proteins
188 rdf:type schema:DefinedTerm
189 Nfe15d6983ada44de99dea6b79419b45c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Immunotherapy, Adoptive
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
196 schema:name Oncology and Carcinogenesis
197 rdf:type schema:DefinedTerm
198 sg:journal.1105545 schema:issn 1068-9265
199 1534-4681
200 schema:name Annals of Surgical Oncology
201 rdf:type schema:Periodical
202 sg:person.01033554132.23 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
203 schema:familyName Lionetto
204 schema:givenName Rita
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033554132.23
206 rdf:type schema:Person
207 sg:person.01100026616.95 schema:affiliation N6ac977dfe83f4b48b6923d2b1717b510
208 schema:familyName Sertoli
209 schema:givenName Mario R.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100026616.95
211 rdf:type schema:Person
212 sg:person.01102114523.12 schema:affiliation Nac1a370dafe443b1b0b0dc988ccbeda4
213 schema:familyName Queirolo
214 schema:givenName Paola
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102114523.12
216 rdf:type schema:Person
217 sg:person.01110652473.89 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
218 schema:familyName Ponte
219 schema:givenName Marco
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110652473.89
221 rdf:type schema:Person
222 sg:person.01130076740.81 schema:affiliation N9d08dfd14f4549b0955a7abe9dea43a0
223 schema:familyName Cafiero
224 schema:givenName Ferdinando
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130076740.81
226 rdf:type schema:Person
227 sg:person.01135120604.05 schema:affiliation N0814fd383d0147d780673f1ffcb7b367
228 schema:familyName Vecchio
229 schema:givenName Stefania
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135120604.05
231 rdf:type schema:Person
232 sg:person.01140414625.71 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
233 schema:familyName Pietra
234 schema:givenName Gabriella
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140414625.71
236 rdf:type schema:Person
237 sg:person.01141433133.33 schema:affiliation N88c94b78f0fb4ebdac4c1678a7e244e8
238 schema:familyName Ribizzi
239 schema:givenName Iole
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141433133.33
241 rdf:type schema:Person
242 sg:person.01156230741.17 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
243 schema:familyName Peressini
244 schema:givenName Alberto
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156230741.17
246 rdf:type schema:Person
247 sg:person.01264406000.09 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
248 schema:familyName Semino
249 schema:givenName Claudia
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264406000.09
251 rdf:type schema:Person
252 sg:person.01272275041.40 schema:affiliation N3f13e6a7bb424c0a8bf9121269693962
253 schema:familyName Gipponi
254 schema:givenName Marco
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272275041.40
256 rdf:type schema:Person
257 sg:person.01274627641.56 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
258 schema:familyName Melioli
259 schema:givenName Giovanni
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274627641.56
261 rdf:type schema:Person
262 sg:pub.10.1038/291335a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036146781
263 https://doi.org/10.1038/291335a0
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/bjc.1995.66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048333305
266 https://doi.org/10.1038/bjc.1995.66
267 rdf:type schema:CreativeWork
268 https://app.dimensions.ai/details/publication/pub.1080018650 schema:CreativeWork
269 https://doi.org/10.1002/(sici)1097-0142(19960715)78:2<244::aid-cncr9>3.0.co;2-l schema:sameAs https://app.dimensions.ai/details/publication/pub.1022318742
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1002/(sici)1097-0215(19960208)65:4<413::aid-ijc3>3.0.co;2-# schema:sameAs https://app.dimensions.ai/details/publication/pub.1051801158
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049278910
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1002732031
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1002/ijc.2910280307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011013967
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1016/0197-2456(89)90015-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053744925
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1016/s0140-6736(89)91609-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021609526
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1056/nejm198704093161502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016780262
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1084/jem.155.6.1823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035987844
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1084/jem.161.5.1169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008495351
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1093/jnci/75.4.595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1080008874
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1093/jnci/86.15.1159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059818758
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1093/oxfordjournals.annonc.a058261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076800116
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1097/00000658-198910000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003070692
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1097/00008390-199404000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008747279
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1126/science.181845 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062508258
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1126/science.3489291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062616710
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1126/science.6332379 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062636819
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1200/jco.1984.2.4.336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1081679323
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1200/jco.1989.7.11.1726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079394454
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1200/jco.1989.7.12.1863 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079223212
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1200/jco.1990.8.10.1657 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078482791
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1200/jco.1990.8.7.1138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716990
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1200/jco.1991.9.4.641 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078193758
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1200/jco.1992.10.2.275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077377500
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1200/jco.1993.11.10.1969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082794839
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1200/jco.1994.12.7.1475 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082613204
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1200/jco.1994.12.8.1572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082622190
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1200/jco.1995.13.8.1939 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082444239
326 rdf:type schema:CreativeWork
327 https://doi.org/10.3892/or.4.1.27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071535320
328 rdf:type schema:CreativeWork
329 https://www.grid.ac/institutes/grid.5606.5 schema:alternateName University of Genoa
330 schema:name Advanced Biotechnology Center, National Cancer Institute of Genoa, Genoa, Italy
331 Surgical Oncology, University of Genoa, Genoa, Italy
332 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...